KL and hepatocellular carcinoma: constructed a Cox risk model for hepatocellular carcinoma involving eight genes (e.g., ARHGEF37, NR6A1), finding that patients with high-risk scores had lower survival rates, with high-risk scores (correlated with Kla-related gene expression) negatively associated with low NK cell scores, suggesting Kla promotes tumor immune escape by inhibiting NK cell activity.